Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: Polycystic ovary syndrome (PCOS) is a common multisystem disorder with reproductive, cardiometabolic and psychological implications. Genetic factors play a role in the pathogenesis of PCOS. We sought to investigate the cardiometabolic health of first degree relatives (FDR) of women with PCOS.
Design: Systematic review and meta-analysis.
Methods: Medline, Embase, PsycInfo, allEBM (Ovid), clinicaltrials.gov and WHO ICTRP were searched from inception until 1st November 2023. Randomised controlled trials, observational studies, evidence-based guidelines, systematic reviews and health technology assessments reporting on cardiometabolic health of FDRs of women with PCOS compared to participants without a family history of PCOS (controls) were included. Primary outcomes of interest were cardiovascular disease and cardiometabolic risk factors. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were adhered to for the systematic review and meta-analysis.
Results: The search strategy identified 20,639 publications of which 68 publications representing 34 unique studies were included. FDRs of women with PCOS had higher rates of metabolic syndrome (OR: 2.50; 95% CI: 1.40-4.45, I = 65%; six studies; 2059 participants; p = 0.002), hypertension (OR: 2.05; 95% CI: 1.08-3.92, I = 0%; three studies; 302 participants; p = 0.03) and diabetes (OR: 2.46; 95% CI: 1.31-4.62, I2 = 9%; five studies; 778 participants; p = 0.005) compared with controls. Additionally, measures of glucose control and lipid profile were worse in FDRs of women with PCOS compared with controls. Most studies were judged as moderate risk of bias. No published data on CVD were identified.
Conclusions: FDRs of women with PCOS are at increased risk of cardiometabolic disorders.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/cen.15294 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Patient and First-Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease-A Multinational Survey.
United European Gastroenterol J
August 2025
Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Portugal.
Background And Objective: While significant advances have been made in identifying biomarkers for predicting inflammatory bowel disease (IBD) onset, little is known about the willingness of at-risk individuals to undergo predictive testing and preventive interventions. This study aimed to assess acceptance of predictive tests and preventive interventions among individuals at risk of inflammatory bowel disease and identify factors influencing their decisions.
Methods: An anonymized electronic survey was distributed to parents of children at risk of inflammatory bowel disease and first-degree relatives (FDRs) of IBD patients via clinicians and patient associations.
Familial risk of carpal tunnel syndrome among first-degree relatives and interaction with obesity and hyperglycemia-a population-based study in Korea.
Pain
July 2025
Cochrane Korea, Seoul, Korea.
Although genetic and lifestyle factors are known to be involved in carpal tunnel syndrome development, population-level familial risk and interactions between gene and environmental factors have been scarcely studied. We investigated population-based familial risk and assessed the interactions between family history and obesity or hyperglycemia. By using the National Health Insurance database, which covers the total population in Korea, we constructed a cohort of 5,524,403 individuals with information on familial relationships and lifestyle factors from 2002 to 2019.
View Article and Find Full Text PDFEffects of combined estrogen and bazedoxifene (CEB) on depressive symptoms in perimenopause.
J Affect Disord
December 2025
Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Background: Perimenopause is characterized by ovarian hormone fluctuation and associated with elevated risk for depression. Perimenopausal-onset major depression (PO-MDD) can be alleviated with estrogen treatment. However, due to potential risk for breast and uterine cancer, traditional hormone treatments may not be suitable for some.
View Article and Find Full Text PDFCardiometabolic Risk in First Degree Relatives of Women With Polycystic Ovary Syndrome (PCOS).
Clin Endocrinol (Oxf)
June 2025
Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
Objective: Polycystic ovary syndrome (PCOS) is a common multisystem disorder with reproductive, cardiometabolic and psychological implications. Genetic factors play a role in the pathogenesis of PCOS. We sought to investigate the cardiometabolic health of first degree relatives (FDR) of women with PCOS.
View Article and Find Full Text PDFThe cost-utility of targeted germline BRCA testing in localized prostate cancer followed by cascade testing first-degree relatives with pathogenic variants.
Genet Med
August 2025
Centre for the Business and Economics of Health, The University of Queensland, Brisbane, QLD, Australia.
Purpose: Genetic testing is recommended in localized prostate cancer (PCa) with elevated risk and in metastatic PCa. The economics of genetic testing in metastatic PCa has been evaluated but not assessed in localized PCa. We examined the cost utility of germline BRCA testing in localized PCa with high risk of pathogenic variants.
View Article and Find Full Text PDF